NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

That portion would speed things in that we remain the “national route”, which we are, and the “recognition routes” are transferred to the recognition pathway, thus making DCVax-l in an easier/smaller to process group of applications constituting the “national route.”

Plus, the March 1 MHRA assessment modifications I previously linked, copy and pasted, will speed processing for the National route even more. See https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173931019